Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Active and recent NIH-funded research on Congenital Toxoplasmosis. Data from NIH RePORTER, last 36 months.
Congenital Toxoplasmosis has emerging NIH research funding with 4 grants totaling $4.3M.
NIH fiscal year (Oct–Sep)
Cross-referencing NIH grants against published research and clinical trials to identify funding-evidence gaps for Congenital Toxoplasmosis. Strongest funded area: Basic Science. Largest gap: Biomarker / Diagnostics.
1 clinical trial registered but no NIH-funded clinical or translational research grants found for congenital toxoplasmosis. Trials may be industry-sponsored or funded through non-NIH sources.
8 publications in Diagnostic / Biomarker but no NIH-funded grants found in Biomarker / Diagnostics for congenital toxoplasmosis. Existing research activity suggests this may be a viable area for grant applications.
These grants mention Congenital Toxoplasmosis as part of broader research but are not primarily focused on this disease. They are not included in the funding totals above.